Bone Therapeutics SA

Informe acción ENXTBR:BOTHE

Capitalización de mercado: €3.4m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Bone Therapeutics Dirección

Dirección controles de criterios 4/4

Información clave

Miguel Forte

Chief Executive Officer (CEO)

€339.1k

Compensación total

Porcentaje del salario del CEO94.2%
Permanencia del CEO3.8yrs
Participación del CEOn/a
Permanencia media de la dirección2.2yrs
Promedio de permanencia en la Junta Directiva3yrs

Actualizaciones recientes de la dirección

Recent updates

Is Bone Therapeutics (EBR:BOTHE) A Risky Investment?

May 26
Is Bone Therapeutics (EBR:BOTHE) A Risky Investment?

What Type Of Returns Would Bone Therapeutics'(EBR:BOTHE) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 16
What Type Of Returns Would Bone Therapeutics'(EBR:BOTHE) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Miguel Forte en comparación con los beneficios de Bone Therapeutics?
FechaCompensación totalSalarioIngresos de la empresa
Jun 30 2022n/an/a

-€10m

Mar 31 2022n/an/a

-€11m

Dec 31 2021€339k€319k

-€13m

Sep 30 2021n/an/a

-€13m

Jun 30 2021n/an/a

-€14m

Mar 31 2021n/an/a

-€15m

Dec 31 2020€432k€300k

-€16m

Compensación vs. Mercado: Miguel's total compensation ($USD335.14K) is below average for companies of similar size in the Belgian market ($USD492.28K).

Compensación vs. Ingresos: Miguel's compensation has been consistent with company performance over the past year.

CEO

Miguel Forte (62 yo)

3.8yrs

Permanencia

€339,127

Compensación

Dr. Miguel Forte, M.D., Ph D., serves as Chief Executive Officer and Executive Director at Bone Therapeutics SA since December 2019 and 2020 respectively and serves as its Managing Director. He serves as D...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Miguel Forte
CEO, MD & Executive Director3.8yrs€339.13ksin datos
Anne-Sophie Lebrun
Chief Operations Officer2.2yrssin datossin datos
Anthony Ting
Chief Scientific Officer1.5yrssin datossin datos
Gunther De Backer
Head of Corporate Communications & Investor Relationsno datasin datossin datos
Valerie Chapelle
Interim HR Directorno datasin datossin datos
Stefanos Theoharis
Chief Business Officer2.6yrssin datossin datos
Anne Leselbaum
Chief Medical Officer1.2yrssin datossin datos
Ching Choi
Business Development Managerno datasin datossin datos

2.2yrs

Permanencia media

56yo

Promedio de edad

Equipo directivo experimentado: BOTHE's management team is considered experienced (2.2 years average tenure).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Miguel Forte
CEO, MD & Executive Director2.8yrs€339.13ksin datos
Claudia D'Augusta
Independent Director4.5yrs€30.00ksin datos
Frank Barry
Member of Scientific Advisory Boardless than a yearsin datossin datos
Baron Stephenne
Independent Chairman of the Board4.7yrs€50.00ksin datos
Damian Marron
Independent Director5.3yrs€25.00ksin datos
Richard Maziarz
Member of Scientific Advisory Boardless than a yearsin datossin datos
Jean-Paul Prieels
Independent Director7.6yrs€25.00ksin datos
Jean-Luc Vandebroek
Non-Executive Director4.3yrssin datossin datos
Gloria Matthews
Independent Director3.3yrs€20.00ksin datos
Massimo Dominici
Chair of Scientific Advisory Boardless than a yearsin datossin datos
Patricia Rocco
Member of Scientific Advisory Boardless than a yearsin datossin datos
Robert Deans
Member of Scientific Advisory Boardless than a yearsin datossin datos

3.0yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: BOTHE's board of directors are considered experienced (3 years average tenure).